Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för David Altshuler. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att David Altshuler har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:VRTX / Vertex Pharmaceuticals Incorporated | EVP, Chief Scientific Officer | 23 281 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av David Altshuler. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av David Altshuler som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −52 | 23 281 | −0,22 | 424,69 | −22 084 | 9 887 208 |
2025-03-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 231 | 23 281 | −12,19 | 510,00 | −1 647 810 | 11 873 310 |
2025-03-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 231 | 26 512 | −10,86 | 500,00 | −1 615 500 | 13 256 000 |
2025-03-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 231 | 29 743 | −9,80 | 490,00 | −1 583 190 | 14 574 070 |
2025-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 272 | 32 974 | −3,71 | 480,00 | −610 560 | 15 827 520 |
2025-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −5 954 | 34 246 | −14,81 | 479,61 | −2 855 598 | 16 424 724 | |
2025-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −848 | 40 200 | −2,07 | 480,95 | −407 846 | 19 334 190 |
2025-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 971 | 41 048 | −8,82 | 483,28 | −1 919 105 | 19 837 677 | |
2025-02-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 111 | 45 019 | −2,41 | 480,00 | −533 280 | 21 609 120 |
2025-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 293 | 46 130 | −4,74 | 463,46 | −1 062 714 | 21 379 410 | |
2025-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 5 324 | 48 423 | 12,35 | ||||
2025-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 142 | 43 099 | −4,73 | 467,98 | −1 002 413 | 20 169 470 | |
2025-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 114 | 45 241 | 18,66 | ||||
2025-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 314 | 38 127 | 47,70 | ||||
2024-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 | 25 813 | −0,06 | 478,56 | −7 178 | 12 353 069 |
2024-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −54 | 25 813 | −0,21 | 430,93 | −23 270 | 11 123 596 |
2024-02-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 239 | 25 813 | −14,11 | 425,70 | −1 804 542 | 10 988 594 |
2024-02-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 970 | 30 052 | −11,67 | 431,79 | −1 714 206 | 12 976 153 | |
2024-02-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 002 | 34 022 | −8,11 | 421,77 | −1 266 154 | 14 349 459 |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 002 | 37 024 | −9,75 | 420,79 | −1 684 002 | 15 579 329 |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 812 | 41 026 | −6,41 | 420,58 | −1 182 671 | 17 254 715 | |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 750 | 43 838 | −7,88 | 424,01 | −1 590 038 | 18 587 750 | |
2024-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 145 | 47 588 | −6,20 | 420,24 | −1 321 655 | 19 998 381 |
2024-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 099 | 50 733 | −3,97 | 422,74 | −887 331 | 21 446 868 | |
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 114 | 52 832 | 15,56 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 866 | 45 718 | 20,78 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 5 814 | 37 852 | 18,15 | ||||
2023-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −19 | 32 038 | −0,06 | 369,92 | −7 028 | 11 851 497 |
2023-08-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −63 | 32 038 | −0,20 | 345,51 | −21 767 | 11 069 449 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −302 | 32 038 | −0,93 | 289,60 | −87 459 | 9 278 205 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 32 340 | −0,92 | 288,74 | −86 622 | 9 337 852 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 636 | 32 640 | −10,02 | 287,23 | −1 044 368 | 9 375 187 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 970 | 36 276 | −9,86 | 289,12 | −1 147 806 | 10 488 117 | |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 40 246 | −2,19 | 294,73 | −265 257 | 11 861 704 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 843 | 41 146 | −4,29 | 294,03 | −541 897 | 12 098 158 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 223 | 42 989 | −2,77 | 292,76 | −358 045 | 12 585 460 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −36 | 44 212 | −0,08 | 291,01 | −10 476 | 12 866 134 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 750 | 44 248 | −7,81 | 292,85 | −1 098 188 | 12 958 027 | |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −308 | 47 998 | −0,64 | 301,02 | −92 714 | 14 448 358 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 888 | 48 306 | −3,76 | 300,11 | −566 608 | 14 497 114 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 165 | 50 194 | −4,13 | 299,08 | −647 508 | 15 012 022 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −395 | 52 359 | −0,75 | 297,97 | −117 698 | 15 601 411 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −842 | 52 754 | −1,57 | 296,85 | −249 948 | 15 660 025 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −800 | 53 596 | −1,47 | 295,79 | −236 632 | 15 853 161 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 54 396 | −0,91 | 300,23 | −150 115 | 16 331 311 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 893 | 54 896 | −3,33 | 299,36 | −566 688 | 16 433 667 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 160 | 56 789 | −3,66 | 298,47 | −644 695 | 16 949 813 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −245 | 58 949 | −0,41 | 296,44 | −72 628 | 17 474 842 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −5 990 | 59 194 | −9,19 | 298,26 | −1 786 577 | 17 655 202 | |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 461 | 65 184 | −5,04 | 294,33 | −1 018 676 | 19 185 607 | |
2023-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −153 | 68 645 | −0,22 | 309,06 | −47 286 | 21 215 424 |
2023-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −620 | 68 798 | −0,89 | 306,70 | −190 154 | 21 100 347 |
2023-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −349 | 69 418 | −0,50 | 305,08 | −106 473 | 21 178 043 |
2023-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 69 767 | −0,14 | 303,64 | −30 364 | 21 184 052 |
2023-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −70 | 69 867 | −0,10 | 302,00 | −21 140 | 21 099 834 |
2023-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 | 69 937 | −0,02 | 300,39 | −3 605 | 21 008 375 |
2023-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 304 | 69 949 | 1,90 | 187,53 | 244 539 | 13 117 536 | |
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 866 | 68 645 | 12,94 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 314 | 60 779 | 25,41 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 388 | 48 465 | 34,34 | ||||
2022-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −34 | 36 077 | −0,09 | 308,61 | −10 493 | 11 133 723 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −83 | 36 077 | −0,23 | 306,57 | −25 445 | 11 060 126 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −140 | 36 160 | −0,39 | 305,39 | −42 755 | 11 042 902 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −280 | 36 300 | −0,77 | 304,58 | −85 282 | 11 056 254 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −261 | 36 580 | −0,71 | 303,21 | −79 138 | 11 091 422 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −189 | 36 841 | −0,51 | 301,99 | −57 076 | 11 125 614 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 37 030 | −0,56 | 300,96 | −63 202 | 11 144 549 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −140 | 37 240 | −0,37 | 299,72 | −41 961 | 11 161 573 |
2022-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 303 | 37 380 | 3,61 | 187,53 | 244 352 | 7 009 871 | |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −146 | 36 077 | −0,40 | 295,14 | −43 090 | 10 647 766 |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −302 | 36 223 | −0,83 | 293,99 | −88 785 | 10 649 200 |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 36 525 | −0,57 | 293,02 | −61 534 | 10 702 556 |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −424 | 36 735 | −1,14 | 291,53 | −123 609 | 10 709 355 |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −222 | 37 159 | −0,59 | 290,32 | −64 451 | 10 788 001 |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 304 | 37 381 | 3,61 | 187,53 | 244 539 | 7 010 059 | |
2022-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 604 | 36 077 | −15,47 | 289,48 | −1 911 726 | 10 443 570 |
2022-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 737 | 42 681 | −11,85 | 288,67 | −1 656 100 | 12 320 724 |
2022-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 561 | 48 418 | −8,61 | 287,83 | −1 312 793 | 13 936 153 |
2022-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −963 | 52 979 | −1,79 | 286,72 | −276 111 | 15 190 139 |
2022-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 338 | 53 942 | 15,75 | 155,57 | 1 141 573 | 8 391 757 | |
2022-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 427 | 46 604 | 28,82 | 187,53 | 1 955 375 | 8 739 648 | |
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −560 | 36 077 | −1,53 | 232,68 | −130 301 | 8 394 396 |
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 784 | 36 637 | −7,06 | 231,64 | −644 886 | 8 486 595 |
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 188 | 39 421 | −7,48 | 230,62 | −735 217 | 9 091 271 |
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 040 | 42 609 | −2,38 | 229,41 | −238 586 | 9 774 931 |
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −6 038 | 43 649 | −12,15 | 227,86 | −1 375 819 | 9 945 861 | |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 038 | 49 687 | −2,05 | 233,27 | −242 134 | 11 590 486 |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −600 | 50 725 | −1,17 | 231,85 | −139 110 | 11 760 591 |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −385 | 51 325 | −0,74 | 231,01 | −88 939 | 11 856 588 |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 303 | 51 710 | −2,46 | 230,05 | −299 755 | 11 895 886 |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −986 | 53 013 | −1,83 | 229,22 | −226 011 | 12 151 640 |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 439 | 53 999 | −5,99 | 232,51 | −799 602 | 12 555 307 | |
2022-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 444 | 57 438 | −4,08 | 232,02 | −567 057 | 13 326 765 |
2022-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −98 | 59 882 | −0,16 | 237,23 | −23 249 | 14 205 807 |
2022-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −601 | 59 980 | −0,99 | 236,28 | −142 004 | 14 172 074 |
2022-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −757 | 60 581 | −1,23 | 234,95 | −177 857 | 14 233 506 |
2022-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −841 | 61 338 | −1,35 | 233,92 | −196 727 | 14 348 185 |
2022-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 518 | 62 179 | −5,35 | 237,74 | −836 369 | 14 782 435 | |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 660 | 0 | −100,00 | 86,52 | −403 183 | ||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 65 697 | −0,45 | 254,46 | −76 338 | 16 717 259 |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 099 | 65 997 | −1,64 | 253,41 | −278 498 | 16 724 300 |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 67 096 | −1,32 | 252,10 | −226 890 | 16 914 902 |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −980 | 67 996 | −1,42 | 251,22 | −246 196 | 17 081 955 |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −754 | 68 976 | −1,08 | 249,97 | −188 477 | 17 241 931 |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −127 | 69 730 | −0,18 | 248,65 | −31 579 | 17 338 364 |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 69 857 | −0,71 | 247,73 | −123 865 | 17 305 675 |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 660 | 70 357 | 7,09 | 86,52 | 403 183 | 6 087 288 | |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 314 | 65 697 | 23,07 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 628 | 53 383 | 27,85 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 166 | 41 755 | 24,31 | ||||
2021-11-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −20 | 33 589 | −0,06 | 187,51 | −3 750 | 6 298 273 |
2021-11-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −14 | 33 609 | −0,04 | 186,80 | −2 615 | 6 278 161 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 | 33 589 | −0,04 | 217,13 | −3 257 | 7 293 180 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −56 | 33 604 | −0,17 | 216,31 | −12 113 | 7 268 881 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 | 33 660 | −0,02 | 215,31 | −1 722 | 7 247 335 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −354 | 33 589 | −1,04 | 216,26 | −76 556 | 7 263 957 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −680 | 33 943 | −1,96 | 214,28 | −145 710 | 7 273 306 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 348 | 34 623 | −3,75 | 213,05 | −287 191 | 7 376 430 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −646 | 35 971 | −1,76 | 211,58 | −136 681 | 7 610 744 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 416 | 36 617 | −6,19 | 217,57 | −525 649 | 7 966 761 | |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 39 033 | −0,51 | 213,26 | −42 652 | 8 324 178 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 033 | 39 233 | −4,93 | 212,59 | −432 195 | 8 340 543 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 513 | 41 266 | −9,86 | 211,84 | −956 034 | 8 741 789 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 079 | 45 779 | −2,30 | 210,11 | −226 709 | 9 618 626 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −6 240 | 46 858 | −11,75 | 211,75 | −1 321 320 | 9 922 182 | |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 53 098 | −0,93 | 211,67 | −105 835 | 11 239 254 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 783 | 53 598 | −8,19 | 210,42 | −1 006 439 | 11 278 091 |
2021-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 974 | 58 381 | −4,85 | 214,16 | −636 912 | 12 502 875 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 627 | 61 355 | 23,38 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 388 | 49 728 | 33,18 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 438 | 37 340 | 29,20 | ||||
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 28 902 | −0,03 | 224,32 | −2 243 | 6 483 297 |
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −18 | 28 912 | −0,06 | 223,57 | −4 024 | 6 463 856 |
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 28 930 | −0,03 | 222,45 | −2 224 | 6 435 478 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 223 | 7 338 | −14,29 | ||||
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −310 | 28 902 | −1,06 | 272,60 | −84 506 | 7 878 685 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −423 | 29 212 | −1,43 | 271,39 | −114 798 | 7 927 845 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −490 | 29 635 | −1,63 | 270,12 | −132 359 | 8 005 006 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 223 | 30 125 | 4,23 | 155,57 | 190 262 | 4 686 546 | |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 330 | 4 660 | −33,33 | ||||
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 28 902 | −0,34 | 279,98 | −27 998 | 8 091 982 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −605 | 29 002 | −2,04 | 279,19 | −168 910 | 8 097 068 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 167 | 29 607 | −3,79 | 278,14 | −324 589 | 8 234 891 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −458 | 30 774 | −1,47 | 276,84 | −126 793 | 8 519 474 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 31 232 | 8,06 | 86,52 | 201 592 | 2 702 193 | |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −19 | 28 902 | −0,07 | 288,05 | −5 473 | 8 325 221 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 | 28 921 | −0,05 | 287,19 | −4 308 | 8 305 822 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 28 936 | −0,03 | 286,12 | −2 861 | 8 279 168 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 | 28 946 | −0,02 | 284,98 | −1 425 | 8 249 031 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 | 28 951 | −0,01 | 283,74 | −851 | 8 214 557 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 | 28 954 | −0,02 | 282,77 | −1 697 | 8 187 323 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 | 28 960 | −0,01 | 281,55 | −1 126 | 8 153 688 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 | 28 964 | −0,03 | 280,47 | −2 524 | 8 123 533 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 | 28 973 | −0,02 | 279,48 | −1 397 | 8 097 374 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 | 28 978 | −0,01 | 276,44 | −1 106 | 8 010 678 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 | 28 982 | −0,01 | 274,98 | −550 | 7 969 470 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 304 | 14 338 | −8,34 | ||||
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 304 | 28 902 | −4,32 | 287,33 | −374 678 | 8 304 412 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 304 | 30 206 | 4,51 | 187,53 | 244 539 | 5 664 531 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 222 | 8 561 | −12,49 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −280 | 28 902 | −0,96 | 274,35 | −76 818 | 7 929 264 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −461 | 29 182 | −1,56 | 273,45 | −126 060 | 7 979 818 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 29 643 | −0,70 | 271,87 | −57 093 | 8 059 042 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −271 | 29 853 | −0,90 | 270,20 | −73 224 | 8 066 281 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 222 | 30 124 | 4,23 | 155,57 | 190 107 | 4 686 391 | |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 330 | 6 990 | −25,00 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −193 | 28 902 | −0,66 | 264,78 | −51 103 | 7 652 672 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 29 095 | −1,69 | 262,45 | −131 225 | 7 635 983 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −237 | 29 595 | −0,79 | 261,31 | −61 930 | 7 733 469 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 29 832 | −2,29 | 260,17 | −182 119 | 7 761 391 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 30 532 | −2,24 | 259,18 | −181 426 | 7 913 284 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 31 232 | 8,06 | 86,52 | 201 592 | 2 702 193 | |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −480 | 28 902 | −1,63 | 238,33 | −114 398 | 6 888 214 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −160 | 29 382 | −0,54 | 236,80 | −37 888 | 6 957 658 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −280 | 29 542 | −0,94 | 235,53 | −65 948 | 6 958 027 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −574 | 29 822 | −1,89 | 234,52 | −134 614 | 6 993 855 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 30 396 | −1,30 | 232,51 | −93 004 | 7 067 374 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 30 796 | −1,28 | 230,77 | −92 308 | 7 106 793 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −734 | 31 196 | −2,30 | 229,72 | −168 614 | 7 166 345 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 416 | 31 930 | −7,03 | 239,23 | −577 980 | 7 638 614 | |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −556 | 34 346 | −1,59 | 245,57 | −136 537 | 8 434 347 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −632 | 34 902 | −1,78 | 244,87 | −154 758 | 8 546 453 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −530 | 35 534 | −1,47 | 243,66 | −129 140 | 8 658 214 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 010 | 36 064 | −2,72 | 242,62 | −245 046 | 8 749 848 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 37 074 | −1,07 | 241,80 | −96 720 | 8 964 493 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 496 | 37 474 | −6,24 | 241,50 | −602 784 | 9 049 971 | |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 200 | 39 970 | −2,91 | 248,50 | −298 200 | 9 932 545 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 235 | 41 170 | −5,15 | 247,73 | −553 677 | 10 199 044 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 472 | 43 405 | −7,41 | 246,73 | −856 647 | 10 709 316 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 725 | 46 877 | −10,88 | 245,81 | −1 407 262 | 11 522 835 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 400 | 52 602 | −6,07 | 244,89 | −832 626 | 12 881 704 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 000 | 56 002 | −1,75 | 243,36 | −243 360 | 13 628 647 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −13 308 | 57 002 | −18,93 | 240,95 | −3 206 563 | 13 734 632 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 223 | 9 783 | −11,11 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 303 | 15 642 | −7,69 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −154 | 70 310 | −0,22 | 242,47 | −37 340 | 17 048 066 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −280 | 70 464 | −0,40 | 240,82 | −67 430 | 16 969 140 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −630 | 70 744 | −0,88 | 239,63 | −150 967 | 16 952 385 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 462 | 71 374 | −2,01 | 238,74 | −349 038 | 17 039 829 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | −1 223 | 72 836 | −1,65 | 155,57 | −190 262 | 11 331 097 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | −1 303 | 71 613 | −1,79 | 187,53 | −244 352 | 13 429 586 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 387 | 70 310 | 21,39 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 166 | 57 923 | 16,41 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 18 204 | 49 757 | 57,69 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 330 | 9 320 | −20,00 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 0 | −100,00 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −470 | 31 553 | −1,47 | 232,88 | −109 454 | 7 348 063 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 122 | 32 023 | −6,21 | 231,67 | −491 604 | 7 418 768 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −785 | 34 145 | −2,25 | 230,60 | −181 021 | 7 873 837 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −749 | 34 930 | −2,10 | 229,35 | −171 783 | 8 011 196 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 35 679 | 6,99 | 86,52 | 201 592 | 3 086 947 | |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 33 349 | 5,69 | 91,05 | 163 526 | 3 036 426 | |
2019-11-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | −3 910 | 16 945 | −18,75 | ||||
2019-11-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 910 | 31 553 | −11,03 | 219,37 | −857 737 | 6 921 782 |
2019-11-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 910 | 35 463 | 12,39 | 187,53 | 733 242 | 6 650 376 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −60 | 31 553 | −0,19 | 205,95 | −12 357 | 6 498 340 |
2019-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 223 | 11 006 | −10,00 | ||||
2019-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −210 | 31 553 | −0,66 | 197,90 | −41 559 | 6 244 339 |
2019-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −770 | 31 763 | −2,37 | 197,38 | −151 983 | 6 269 381 |
2019-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −243 | 32 533 | −0,74 | 196,08 | −47 647 | 6 379 071 |
2019-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 223 | 32 776 | 3,88 | 155,57 | 190 262 | 5 098 962 | |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 330 | 11 650 | −16,67 | ||||
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 1 796 | −50,00 | ||||
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −800 | 31 553 | −2,47 | 201,23 | −160 984 | 6 349 410 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 326 | 32 353 | −9,32 | 200,26 | −666 065 | 6 479 012 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 35 679 | 6,99 | 86,52 | 201 592 | 3 086 947 | |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 33 349 | 5,69 | 91,05 | 163 526 | 3 036 426 | |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 669 | 12 229 | −23,08 | ||||
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 669 | 31 553 | −10,42 | 194,37 | −713 144 | 6 132 957 |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 669 | 35 222 | 11,63 | 155,57 | 570 786 | 5 479 487 | |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock (right to buy) |
M - Exercise | 4 659 | 13 980 | 49,98 | ||||
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | 3 592 | 3 592 | |||||
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | 4 250 | 0 | −100,00 | ||||
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 330 | 31 553 | −6,88 | 186,37 | −434 242 | 5 880 533 |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 329 | 33 883 | −6,43 | 186,41 | −434 149 | 6 316 130 |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 659 | 36 212 | 14,77 | 86,52 | 403 097 | 3 133 062 | |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 796 | 31 553 | −5,39 | 186,41 | −334 792 | 5 881 795 |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 796 | 33 349 | −5,11 | 186,37 | −334 721 | 6 215 253 |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 592 | 35 145 | 11,38 | 91,05 | 327 052 | 3 199 952 | |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 250 | 31 553 | −11,87 | 186,37 | −792 072 | 5 880 533 |
2019-08-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 35 803 | 13,47 | 131,89 | 560 532 | 4 722 058 | |
2019-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −91 | 31 553 | −0,29 | 165,41 | −15 052 | 5 219 182 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 31 553 | −1,25 | 188,59 | −75 436 | 5 950 580 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −651 | 31 953 | −2,00 | 187,40 | −121 997 | 5 987 992 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 573 | 32 604 | −12,30 | 186,81 | −854 282 | 6 090 753 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 37 177 | −0,27 | 181,82 | −18 182 | 6 759 522 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 937 | 37 277 | −15,69 | 181,03 | −1 255 805 | 6 748 255 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 836 | 44 214 | −26,37 | 180,33 | −2 855 706 | 7 973 111 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 083 | 60 050 | −14,38 | 179,46 | −1 809 495 | 10 776 573 |
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 20 855 | 20 855 | |||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 166 | 70 133 | 13,18 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 438 | 61 967 | 15,76 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 14 416 | 53 529 | 36,86 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 330 | 18 639 | −11,11 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 7 184 | −20,00 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 330 | 39 113 | −5,62 | 189,19 | −440 813 | 7 399 788 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 41 443 | 5,96 | 86,52 | 201 592 | 3 585 648 | |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 796 | 39 113 | −4,39 | 189,19 | −339 785 | 7 399 788 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 40 909 | 4,59 | 91,05 | 163 526 | 3 724 764 | |
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 4 250 | −33,33 | ||||
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 39 113 | −5,15 | 193,48 | −411 145 | 7 567 583 |
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 41 238 | 5,43 | 131,89 | 280 266 | 5 438 880 | |
2019-01-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 223 | 15 898 | −7,14 | ||||
2019-01-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 223 | 39 113 | −3,03 | 194,62 | −238 020 | 7 612 172 |
2019-01-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 223 | 40 336 | 3,13 | 155,70 | 190 421 | 6 280 315 | |
2018-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 39 113 | −0,26 | 163,75 | −16 375 | 6 404 754 |
2018-11-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 125 | 6 375 | 50,00 | ||||
2018-11-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 39 113 | −5,15 | 181,89 | −386 516 | 7 114 264 |
2018-11-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 41 238 | 5,43 | 131,89 | 280 266 | 5 438 880 | |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 330 | 20 969 | 12,50 | ||||
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 330 | 39 113 | −5,62 | 172,08 | −400 946 | 6 730 565 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 41 443 | 5,96 | 86,52 | 201 592 | 3 585 648 | |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 1 796 | 8 980 | 25,00 | ||||
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 796 | 39 113 | −4,39 | 175,36 | −314 947 | 6 858 856 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 40 909 | 4,59 | 91,05 | 163 526 | 3 724 764 | |
2018-10-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 445 | 17 121 | −12,50 | ||||
2018-10-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 445 | 39 113 | −5,88 | 194,62 | −475 846 | 7 612 172 |
2018-10-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 445 | 41 558 | 6,25 | 155,57 | 380 369 | 6 465 178 | |
2018-08-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 8 500 | −20,00 | ||||
2018-08-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 39 113 | −5,15 | 181,89 | −386 516 | 7 114 264 |
2018-08-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 41 238 | 5,43 | 131,89 | 280 266 | 5 438 880 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 330 | 23 299 | −9,09 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 330 | 39 113 | −5,62 | 174,20 | −405 886 | 6 813 485 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 41 443 | 5,96 | 86,52 | 201 592 | 3 585 648 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 10 776 | −14,29 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 796 | 39 113 | −4,39 | 174,59 | −313 564 | 6 828 739 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 40 909 | 4,59 | 91,05 | 163 526 | 3 724 764 | |
2018-07-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −23 375 | 10 625 | −68,75 | ||||
2018-07-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −23 375 | 39 113 | −37,41 | 182,00 | −4 254 250 | 7 118 566 |
2018-07-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 23 375 | 62 488 | 59,76 | 131,89 | 3 082 929 | 8 241 542 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −11 649 | 25 629 | −31,25 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 12 572 | −12,50 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 000 | 39 113 | −11,33 | 167,04 | −835 200 | 6 533 436 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −31 796 | 44 113 | −41,89 | 165,46 | −5 260 966 | 7 298 937 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 535 | 75 909 | −9,03 | 161,57 | −1 217 430 | 12 264 617 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 11 649 | 83 444 | 16,23 | 86,52 | 1 007 871 | 7 219 575 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 71 795 | 2,57 | 91,05 | 163 526 | 6 536 935 | |
2018-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −98 | 69 999 | −0,14 | 155,78 | −15 266 | 10 904 444 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 69 999 | −0,14 | 153,84 | −15 384 | 10 768 646 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 70 099 | −0,99 | 153,11 | −107 177 | 10 732 858 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 953 | 70 799 | −2,68 | 151,40 | −295 684 | 10 718 969 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 900 | 72 752 | −2,55 | 150,67 | −286 273 | 10 961 544 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 750 | 74 652 | −2,29 | 149,23 | −261 152 | 11 140 318 |
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 19 566 | 19 566 | |||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 437 | 76 402 | 12,41 | ||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 18 204 | 67 965 | 36,58 | ||||
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 14 368 | −11,11 | ||||
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 49 761 | −0,20 | 169,49 | −16 949 | 8 433 992 |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 49 861 | −0,20 | 167,81 | −16 781 | 8 367 174 |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −996 | 49 961 | −1,95 | 166,12 | −165 456 | 8 299 521 |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −600 | 50 957 | −1,16 | 165,24 | −99 144 | 8 420 135 |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 51 557 | 3,61 | 91,05 | 163 526 | 4 694 265 | |
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 16 164 | −10,00 | ||||
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 796 | 49 761 | −3,48 | 160,00 | −287 360 | 7 961 760 |
2018-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 51 557 | 3,61 | 91,05 | 163 526 | 4 694 265 | |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 955 | 49 761 | −7,36 | 159,41 | −630 467 | 7 932 401 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 585 | 53 716 | −16,46 | 158,82 | −1 681 110 | 8 531 175 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 130 | 64 301 | −8,70 | 157,71 | −966 762 | 10 140 911 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −11 767 | 70 431 | −14,32 | 156,63 | −1 843 065 | 11 031 608 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −23 813 | 82 198 | −22,46 | 155,77 | −3 709 351 | 12 803 982 |
2017-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −206 | 106 011 | −0,19 | 149,80 | −30 859 | 15 880 448 |
2017-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 106 217 | −0,09 | 147,71 | −14 771 | 15 689 313 |
2017-09-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 796 | 17 960 | −9,09 | ||||
2017-09-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 796 | 106 011 | −1,67 | 160,00 | −287 360 | 16 961 760 |
2017-09-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 796 | 107 807 | 1,69 | 91,05 | 163 526 | 9 815 827 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −8 979 | 19 756 | −31,25 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −28 979 | 106 011 | −21,47 | 161,00 | −4 665 619 | 17 067 771 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 134 990 | 17,39 | 81,54 | 1 630 800 | 11 007 085 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 979 | 114 990 | 8,47 | 91,05 | 817 538 | 10 469 840 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 500 | 106 011 | −6,61 | 130,00 | −975 000 | 13 781 430 |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 500 | 113 511 | 7,07 | 72,14 | 541 050 | 8 188 684 | |
2017-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −181 | 106 011 | −0,17 | 114,37 | −20 701 | 12 124 478 |
2017-05-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2017-05-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 500 | 106 011 | −6,61 | 120,00 | −900 000 | 12 721 320 |
2017-05-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 500 | 113 511 | 7,07 | 63,14 | 473 550 | 7 167 085 | |
2017-02-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 403 | 106 011 | −5,70 | 87,68 | −561 415 | 9 295 044 |
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 37 278 | 37 278 | |||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 18 204 | 112 414 | 19,32 | ||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 4 794 | 94 210 | 5,36 | 0,01 | 48 | 942 | |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 28 735 | 28 735 | |||||
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 14 416 | 89 416 | 19,22 | 0,01 | 144 | 894 | |
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −5 000 | 7 500 | −40,00 | ||||
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 000 | 75 000 | −6,25 | 131,00 | −655 000 | 9 825 000 |
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 80 000 | 6,67 | 72,14 | 360 700 | 5 771 200 | |
2015-11-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −7 500 | 7 500 | −50,00 | ||||
2015-11-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −7 500 | 7 500 | −50,00 | ||||
2015-11-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 000 | 75 000 | −16,67 | 130,00 | −1 950 000 | 9 750 000 |
2015-11-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 500 | 90 000 | 9,09 | 63,14 | 473 550 | 5 682 600 | |
2015-11-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 500 | 82 500 | 10,00 | 72,14 | 541 050 | 5 951 550 | |
2015-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 34 000 | 34 000 | |||||
2015-01-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 75 000 | 75 000 | 0,01 | 750 | 750 | ||
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 000 | 15 000 | −6,25 | ||||
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 500 | 0 | −100,00 | 119,75 | −419 125 | |
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 500 | 3 500 | 250,00 | 59,55 | 148 875 | 208 425 | |
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 000 | 1 000 | 63,14 | 63 140 | 63 140 | ||
2014-10-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −2 000 | 16 000 | −11,11 | ||||
2014-10-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 114,75 | −229 500 | |
2014-10-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 000 | 2 000 | 63,14 | 126 280 | 126 280 | ||
2014-10-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −1 405 | 18 000 | −7,24 | ||||
2014-10-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 405 | 0 | −100,00 | 109,75 | −154 199 | |
2014-10-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 405 | 1 405 | 63,14 | 88 712 | 88 712 | ||
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −10 595 | 19 405 | −35,32 | ||||
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 112,06 | −11 206 | |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 100 | −75,00 | 110,48 | −33 144 | 11 048 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −695 | 400 | −63,47 | 109,51 | −76 109 | 43 804 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 177 | 1 095 | −66,53 | 108,31 | −235 791 | 118 599 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 942 | 3 272 | −60,17 | 107,56 | −531 562 | 351 936 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 381 | 8 214 | −22,47 | 106,56 | −253 719 | 875 284 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 595 | 10 595 | 63,14 | 668 968 | 668 968 | ||
2014-09-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −2 500 | 2 500 | −50,00 | ||||
2014-09-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 114,75 | −286 875 | |
2014-09-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 500 | 2 500 | 59,55 | 148 875 | 148 875 | ||
2014-09-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −2 500 | 5 000 | −33,33 | ||||
2014-09-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 109,75 | −274 375 | |
2014-09-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 500 | 2 500 | 59,55 | 148 875 | 148 875 | ||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −5 000 | 7 500 | −40,00 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 104,75 | −261 875 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 500 | 2 500 | −50,00 | 99,75 | −249 375 | 249 375 |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 5 000 | 59,55 | 297 750 | 297 750 | ||
2014-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −2 500 | 12 500 | −16,67 | ||||
2014-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 94,75 | −236 875 | |
2014-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 500 | 2 500 | 59,55 | 148 875 | 148 875 | ||
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −5 000 | 15 000 | −25,00 | ||||
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 91,36 | −9 136 | |
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 351 | 900 | −72,32 | 89,69 | −210 861 | 80 721 |
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 749 | 3 251 | −34,98 | 88,76 | −155 241 | 288 559 |
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 5 000 | 59,55 | 297 750 | 297 750 | ||
2014-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −800 | 100 | −88,89 | 90,86 | −72 688 | 9 086 |
2014-06-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 20 000 | 20 000 | |||||
2013-06-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 20 000 | 20 000 | |||||
2012-06-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 20 000 | 20 000 | |||||
2012-05-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 30 000 | 30 000 | |||||
2012-05-29 | 3 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
0 |